Prevalence of Using Performance-enhancing Substances among Gym Users in Makkah, Saudi Arabia

Ahmad Alabbasi^1, and Khalid Abdullah Almasaodi²

¹Joint Program of Family Medicine, Makkah, Kingdom of Saudi Arabia

²Family Medicine Consultant, Makkah Public Health, Ministry of Health, Saudi Arabia

Cite this paper:
Ahmad Alabbasi and Khalid Abdullah Almasaodi. Prevalence of Using Performance-enhancing Substances among Gym Users in Makkah, Saudi Arabia. American Journal of Medical Sciences and Medicine. 2021; 9(1):17-25. doi: 10.12691/ajmsm-9-1-4

Abstract

Performance-enhancing substances (PESs) have unfortunately become ubiquitous in numerous sports; some of these substances pose a serious threat to the health and well-being of athletes. This study aimed to: assess the prevalence and determinants of PESs use among gym attenders in Makkah, Saudi Arabia Research design: a cross-sectional study. Subjects: a number of 122 adult gymnasts in Makkah city. Tool: The data was collected through an on line self-administered questionnaire. Results: This study revealed that 40% of participants using PESs, 63.8 % of them knew the chemical composition of PESs, majority of them having PESs from online shopping and fitness stores. Participants using PESs for improving appearance, sexuality and power. The duration of usage was less than six months and stop for causes other than price or side effects. The most common used PESs were creatine, alagenin and beta alanine. There were a statistical significance difference between the type of PESs used and age, gender and education while there was no statistical significance difference between the type of PESs used and marital status. Conclusion: less than half of participants using PESs for less than six months, significant differences were found between PESs and gender, age and education. Recommendations: counseling and education for gym users about the adverse effects of PESs, strict regulations should be done for screening and manipulating these substances.

Keywords:
prevalence performance enhancing substances gym users

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Haerinejad, M. J., Ostovar, A., Farzaneh, M. R., & Keshavarz, M. (2016). The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian journal of sports medicine, 7(3).‏
[2]	Mason, M. A., Giza, M., Clayton, L., Lonning, J., & Wilkerson, R. D. (2001). Use of nutritional supplements by high school football and volleyball players. The Iowa Orthopaedic Journal, 21, 43.‏
[3]	Pope Jr, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine reviews, 35(3), 341-375.‏
[4]	Brennan, B. P., Kanayama, G., Hudson, J. I., & Pope, Jr, H. G. (2011). Human growth hormone abuse in male weightlifters. The American journal on addictions, 20(1), 9-13.‏
[5]	Toohey, K., & Beaton, A. (2017). International cross-sector social partnerships between sport and governments: The World Anti-Doping Agency. Sport management review, 20(5), 483-496.‏
[6]	Dietz, P., Ulrich, R., Dalaker, R., Striegel, H., Franke, A. G., Lieb, K., & Simon, P. (2013). Associations between physical and cognitive doping-a cross-sectional study in 2.997 Triathletes. PLoS One, 8(11), e78702.‏
[7]	Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of epidemiology, 24(5), 383-398.‏
[8]	Al Bishi, K. A., & Afify, A. (2017). Prevalence and awareness of anabolic androgenic steroids (AAS) among gymnasts in the western province of Riyadh, Saudi Arabia. Electronic physician, 9(12), 6050.‏
[9]	Al Nozha, O. M., & Elshatarat, R. A. (2017). Influence of knowledge and beliefs on consumption of performance enhancing agents in north-western Saudi Arabia. Annals of Saudi Medicine, 37(4), 317-325.‏
[10]	Aldekhail, N. D. M., Alkredes, A. A., Alkabas, A. S., Al-Saeed, A. A., Alghaidani, M. A., Al-Sohaibani, R. A., & Aljomaiah, S. M. (2018). Knowledge, Attitude and Practice Related to Health Impact of Performance-Enhancing Drugs among the Male Students in Qassim University. The Egyptian Journal of Hospital Medicine, 70(11), 1907-1917.‏
[11]	Nilsson, S., Baigi, A., Marklund, B., & Fridlund, B. (2001). The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. The European Journal of Public Health, 11(2), 195-197.‏
[12]	Buckman, J. F., Yusko, D. A., White, H. R., & Pandina, R. J. (2009). Risk profile of male college athletes who use performance-enhancing substances. Journal of studies on alcohol and drugs, 70(6), 919-923.‏
[13]	Stubbe, J. H., Chorus, A. M., Frank, L. E., de Hon, O., & van der Heijden, P. G. (2014). Prevalence of use of performance enhancing drugs by fitness centre members. Drug testing and analysis, 6(5), 434-438.‏
[14]	Hocaoglu, M., Cevikel, A., Mahsereci, I., Aroglan, E., Dinc, E., Memisoglu, N., & Cakmak, D. (2018). Prevalence of Performance-Enhancing Substances in gym goers in north Cyprus using mixed-methods. European Journal of Public Health, 28(suppl_4), cky213-705.‏
[15]	Momaya, A., Fawal, M., & Estes, R. (2015). Performance-enhancing substances in sports: a review of the literature. Sports Medicine, 45(4), 517-531.‏
[16]	LaBotz, M., & Griesemer, B. A. (2016). Use of performance-enhancing substances. Pediatrics, 138(1).‏
[17]	Nakhaee, M. R., Pakravan, F., & Nakhaee, N. (2013). Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addiction & health, 5(3-4), 77.‏
[18]	Stubbe, J. H., Chorus, A. M., Frank, L. E., de Hon, O., & van der Heijden, P. G. (2013). Prevalence of use of performance enhancing drugs by fitness centre members. Drug testing and analysis, 6(5), 434-438.‏
[19]	Laure, P. (1997). Epidemiologic approach of doping in sport. A review. The Journal of sports medicine and physical fitness, 37(3), 218-224.‏